Works matching IS 01145916 AND DT 2025 AND VI 48 AND IP 2
Results: 8
Fracture-Related Safety Reporting of JAK Inhibitors: An Analysis from the WHO Global VigiBase: Fracture Risk of JAK Inhibitors: A. M.-De la Torre et al.
- Published in:
- Drug Safety, 2025, v. 48, n. 2, p. 191, doi. 10.1007/s40264-024-01490-w
- By:
- Publication type:
- Article
Views on the Development and Use of a New Digital Adverse Drug Event Reporting Platform in Australia: A Qualitative Study: Views on an Adverse Drug Event Reporting Platform : E.A. Gebreyohannes et al.
- Published in:
- Drug Safety, 2025, v. 48, n. 2, p. 179, doi. 10.1007/s40264-024-01489-3
- By:
- Publication type:
- Article
Teratogenic Risk Impact and Mitigation (TRIM): Study Protocol for the Development of a Decision Support Tool to Prioritize Medications for Risk Mitigation: Teratogenic Risk Impact and Mitigation (TRIM) Study Protocol: A. G. Winterstein et al.
- Published in:
- Drug Safety, 2025, v. 48, n. 2, p. 107, doi. 10.1007/s40264-024-01488-4
- By:
- Publication type:
- Article
Challenges in the Implementation of EU Risk Minimisation Measures for Medicinal Products in Clinical Practice Guidelines: Mixed Methods Multi-Case Study: Challenges in Implementing EU Risk Minimisation Measures in Clinical Practice Guidelines: M. Møllebæk et al
- Published in:
- Drug Safety, 2025, v. 48, n. 2, p. 161, doi. 10.1007/s40264-024-01487-5
- By:
- Publication type:
- Article
Incidence of Idiosyncratic Drug-Induced Liver Injury Caused by Prescription Drugs: Incidence of DILI Caused by Prescription Drugs: V. L. Chen et al.
- Published in:
- Drug Safety, 2025, v. 48, n. 2, p. 151, doi. 10.1007/s40264-024-01486-6
- By:
- Publication type:
- Article
Drug-Induced Hypouricemia: Drug-Induced Hypouricemia: C. B. Salem et al.
- Published in:
- Drug Safety, 2025, v. 48, n. 2, p. 129, doi. 10.1007/s40264-024-01485-7
- By:
- Publication type:
- Article
Investigation of the Role of Chemical Analysis in Causality Assessment of Herbal and Dietary Supplement-Induced Liver Injury: Role of Chemical Analysis in Causality Assessment: D. Halegoua-DeMarzio et al.
- Published in:
- Drug Safety, 2025, v. 48, n. 2, p. 143, doi. 10.1007/s40264-024-01484-8
- By:
- Publication type:
- Article
Safeguarding Patients in the AI Era: Ethics at the Forefront of Pharmacovigilance: Ethical Considerations for AI-Driven Pharmacovigilance: A. Jain et al.
- Published in:
- Drug Safety, 2025, v. 48, n. 2, p. 119, doi. 10.1007/s40264-024-01483-9
- By:
- Publication type:
- Article